[Respiratory sequelae of viral diseases: from diagnosis to treatment]

Alejandro Teper1, Gilberto Bueno Fischer, Marcus Herbert Jones

  • 1Centro Respiratorio, Hospital de Niños Ricardo Gutierrez, Argentina.

Jornal De Pediatria
|December 17, 2003
PubMed

Insights

Postinfectious bronchiolitis obliterans (BO) in children is typically diagnosed using imaging and clinical history, with most patients experiencing favorable outcomes and good prognosis. Treatment involves long-term corticosteroids and bronchodilators.

Area of Science:

  • Pediatric Pulmonology
  • Infectious Diseases
  • Respiratory Medicine

Context:

  • Postinfectious bronchiolitis obliterans (PIBO) presents significant diagnostic and management challenges for pediatricians.
  • PIBO is a sequela of severe lower respiratory tract infections in early childhood.

Purpose:

  • To review the primary clinical issues in diagnosing, managing, and determining the prognosis of PIBO in pediatric patients.
  • To synthesize current knowledge on PIBO for clinical practice.

Summary:

  • Diagnosis relies on clinical history, characteristic radiological findings (pulmonary insufflation, thickened bronchovascular bundles, air trapping on CT), and reduced expiratory flows on pulmonary function tests.
  • Pulmonary biopsy is generally not required; diagnosis is often established through a combination of clinical presentation and imaging.
  • Treatment commonly involves prolonged use of oral and inhaled corticosteroids and bronchodilators, with antibiotics and physical therapy for exacerbations.

Impact:

  • Most children with PIBO experience a favorable prognosis with gradual pulmonary function improvement and decreased oxygen dependence.
  • A subset of patients may develop progressive hypoxemia and CO2 retention, potentially leading to pulmonary hypertension and cor pulmonale.
  • Overall, PIBO is often mild to moderate, associated with good outcomes and low mortality rates in pediatric populations.
Abstract

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...